Hamilton Lane (NASDAQ:HLNE) Price Target Raised to $120.00

Hamilton Lane (NASDAQ:HLNE – Get Free Report) had its target price increased by research analysts at UBS Group from $115.00 to $120.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group‘s price objective indicates a potential upside of 33.14% from the stock’s previous close.

Several other equities analysts have also issued reports on HLNE. Weiss Ratings upgraded Hamilton Lane from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, August 31st. Morgan Stanley set a $118.00 price target on shares of Hamilton Lane in a research report on Friday, October 16th. JPMorgan Chase & Co. cut their price target on shares of Hamilton Lane from $150.00 to $144.00 and set an “overweight” rating on the stock in a research report on Wednesday. Zacks Research lowered shares of Hamilton Lane from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 19th. Finally, Oppenheimer decreased their price objective on shares of Hamilton Lane from $182.00 to $181.00 and set an “outperform” rating for the company in a report on Thursday, August 27th. Seven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Hamilton Lane currently has an average rating of “Moderate Buy” and an average price target of $126.12.

View Our Latest Stock Analysis on HLNE

Hamilton Lane Trading Down 5.1%

Shares of HLNE stock traded down $4.86 during trading hours on Thursday, reaching $90.13. The company had a trading volume of 760,567 shares, compared to its average volume of 770,919. The company has a 50 day moving average of $90.06 and a 200 day moving average of $97.21. The company has a debt-to-equity ratio of 0.14, a current ratio of 3.37 and a quick ratio of 3.49. The firm has a market cap of $5.01 billion, a price-to-earnings ratio of 13.37 and a beta of 1.16. Hamilton Lane has a 1-year low of $71.88 and a 1-year high of $155.66.

Hamilton Lane (NASDAQ:HLNE – Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $1.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.65 by $0.33. Hamilton Lane had a return on equity of 23.47% and a net margin of 32.40%. The business had revenue of $204.43 million for the quarter, compared to analyst estimates of $215.23 million. During the same period last year, the company earned $1.54 EPS. The firm’s revenue was up 7.1% on a year-over-year basis. On average, equities research analysts anticipate that Hamilton Lane will post 7.47 EPS for the current year.

Institutional Trading of Hamilton Lane

Hedge funds have recently bought and sold shares of the stock. Root Financial Partners LLC bought a new position in Hamilton Lane in the third quarter valued at approximately $27,000. IFP Advisors Inc increased its position in shares of Hamilton Lane by 332.0% during the second quarter. IFP Advisors Inc now owns 419 shares of the company’s stock worth $33,000 after acquiring an additional 322 shares in the last quarter. Fortitude Family Office LLC bought a new stake in shares of Hamilton Lane during the third quarter worth $51,000. Harbor Investment Advisory LLC bought a new stake in shares of Hamilton Lane during the second quarter worth $58,000. Finally, GAMMA Investing LLC raised its holdings in shares of Hamilton Lane by 80.1% during the third quarter. GAMMA Investing LLC now owns 789 shares of the company’s stock worth $69,000 after acquiring an additional 351 shares during the period. 97.40% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Hamilton Lane

Here are the key news stories impacting Hamilton Lane this week:

  • Positive Sentiment: Keefe, Bruyette & Woods raised its price target to $120 from $116 and maintained an outperform rating. Wells Fargo also raised its target, to $114 from $103, with an overweight rating. Keefe, Bruyette & Woods price target Wells Fargo price target
  • Positive Sentiment: Quarterly EPS of $1.98 beat the $1.65 consensus estimate. Fee-related earnings rose 34%; total assets reached $1.1 trillion, up 7% year over year, while evergreen platform AUM climbed 42% to nearly $21 billion. Q2 2027 earnings call highlights Long-term investor takeaways
  • Positive Sentiment: Hamilton Lane raised its dividend for the ninth straight year and outlined a $2.40 fiscal 2027 dividend target, offering support for income-focused investors. Dividend target and partnership
  • Neutral Sentiment: JPMorgan cut its target to $144 from $150 but kept an overweight rating; Oppenheimer trimmed its target slightly to $170 from $171 and maintained outperform. Both remain positive on the shares despite the reductions. JPMorgan price target Oppenheimer price target
  • Positive Sentiment: A new FactSet partnership aims to provide integrated private-markets analytics, potentially extending Hamilton Lane’s reach and data offering. FactSet partnership announcement
  • Negative Sentiment: Revenue of $204.43 million fell short of the $215.23 million consensus, despite growing 7.1% year over year. Coverage also flagged management’s warning about uneven growth and questioned dividend resilience amid a difficult private-markets environment—risks that could help explain continued pressure on the stock. Quarterly results Dividend sustainability analysis

About Hamilton Lane

(Get Free Report)

Hamilton Lane Incorporated (NASDAQ: HLNE) is a global investment management firm specializing in private markets. The company provides investment solutions and advisory services focused on alternative assets, including private equity, private credit, venture capital, growth equity, infrastructure and real assets.

Hamilton Lane serves institutional investors, family offices, financial advisors and high-net-worth individuals. Its offerings include separately managed accounts, customized portfolios, commingled funds, evergreen vehicles and secondary-market strategies.

Further Reading

Analyst Recommendations for Hamilton Lane (NASDAQ:HLNE)

Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.